Cedarburg Pharmaceuticals has acquired InB: Hauser Pharmaceutical Services. The acquisition is intended to strengthen Cedarburg’s position in the rapidly growing CDMO market and “leverage the trusted reputation and synergistic capabilities of both companies to offer clients a more fully-integrated manufacturing platform strategically focused on helping client’s move NCEs to market,” according to a Cedarburg statement. Hauser’s expertise in natural products, isolation / purificatio...